ORKA — Oruka Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Oruka Therapeutics Q2 net loss widens on higher R&D costs
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber
Oruka rises after psoriasis drug pact using Halozyme's injection tech
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy
U.S. STOCKS ON THE MOVE-ICON, Old Dominion, Energy companies
U.S. STOCKS ON THE MOVE-Phillips 66, Cognizant, AbbVie
U.S. STOCKS ON THE MOVE-Biogen, Fair Isaac, General Dynamics
Oruka Therapeutics rises after upsized $700 mln stock offering
Brief: Oruka Therapeutics Announces Pricing Of Upsized $700 Million Underwritten Public Offering
UCB falls on Novartis' results read-across
Oruka dips on equity raise plans following promising psoriasis study
U.S. STOCKS ON THE MOVE-Domino's Pizza, Veradermics, Peloton
U.S. STOCKS ON THE MOVE -Organon, Verizon, Core Scientific